Ethnic differences in respiratory impairment

Thorax

Volumn 69, Issue 1, 2014, Pages 55-62

  Vaz Fragoso, Carlos A ^a,b   McAvay, Gail ^b   Gill, Thomas M ^b   Concato, John ^a,b   Quanjer, Philip H ^c   Van Ness, Peter H ^b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HEALTH CARE POLICY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; SMOKING; SPIROMETRY; VERY ELDERLY;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LUNG DISEASES; MALE; MEXICAN AMERICANS; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY INSUFFICIENCY; SPIROMETRY;

EID: 84890436587     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203631     Document Type: Article

References (35)

1. Chronic Obstructive Pulmonary Disease. American Lung Association State of Lung Disease in Diverse Communities. 2010:35-40. http://www.lung.org/assets/ documents/publications/solddc-chapters/copd.pdf (accessed 3 May 2013).
2. Centers for Disease Control and Prevention. National Center for Health Statistics: National Health Interview Survey Raw Data, 2008. Analysis performed by American Lung Association Research and Program Services using SPSS and SUDAAN software.
3. Centers for Disease Control and Prevention. National Center for Health Statistics. CDC Wonder On-line Database, compiled from Compressed Mortality File 1999-2006 Series 20 No 2L. 2009.
4. Miniati M, Monti S, Stolk J, et al. Value of chest radiography in phenotyping chronic obstructive pulmonary disease. Eur Respir J 2008;31:509-14.
5. Peto R, Speizer FE, Cochrane AL, et al. The relevance in adults of airflow obstruction, but not of mucous hypersecretion, to mortality from chronic lung disease. Am Rev Respir Dis 1983;128:491-500.
6. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005;128:2640-6.
7. Ferguson GT, Enright PL, Buist AS, et al. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest 2000;117:1146-61.
8. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005;26:319-38.
9. Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J 2005;26:948-68.
10. Vaz Fragoso CA, Gill T. Respiratory impairment and the aging lung: a novel paradigm for assessing pulmonary function. J Gerontol Med Sci 2012;67:264-75.
11. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages. Am J Respir Crit Care Med 2008;177:253-60.
12. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the Global Lung Function 2012 equations. Eur Respir J 2012;40:1324-43.
13. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of the forced expiratory volume in 1-second to forced vital capacity in establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010;181:446-51.
14. Vaz Fragoso CA, Gill TM, McAvay G, et al. Evaluating respiratory impairment in middle-aged persons using lambda-mu-sigma derived Z-scores. Respir Care 2011;56:1771-7.
15. Vaz Fragoso CA, Gill TM, McAvay G, et al. Respiratory impairment and mortality in older persons: a novel spirometric approach. J Investig Med 2011;59:1089-95.
16. Vaz Fragoso CA, Concato J, McAvay G, et al. Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores. J Am Geriatr Soc 2011;59:1847-54.
17. Vaz Fragoso CA, Enright PL, McAvay G, et al. Frailty and respiratory impairment in older persons. Am J Med 2012;125:79-86.
18. Vaz Fragoso CA, Gill TM, McAvay G, et al. Respiratory impairment in older persons: when less means more. Am J Med 2013;126:49-57.
19. US Department of Health and Human Services. National Center for Health Statistics. Third National Health and Nutrition Examination Survey, 1988-94, NHANES III Laboratory Data File (CD-ROM), Public Use Data File Documentation Number 76200. Hyattsville, Maryland: Centers for Disease Control and Prevention, 1996. Available from National Technical Information Service, Springfield, Virginia.
20. Wheatcroft G, Cox CS, Lochner KA. Comparative analysis of the NHANES III public-use and restricted-use linked mortality files. Hyattsville, Maryland: National Center for Health Statistics, 2007. http://www.cdc.gov/nchs/data/ datalinkage/h3-mort-compare-2007-final.pdf
21. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 1991;144:1202-18.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995;51:289-300.
23. Cummings SR, Bates D, Black DM. Clinical use of bone densitometry: scientific review. JAMA 2002;288:1889-97.
24. Gross NJ. Chronic obstructive pulmonary disease outcome measurements. Proc Am Thorac Soc 2005;2:267-71.
25. Cherry DK, Burt CW, Woodwell DA. National ambulatory medical care survey: 1999 summary. Adv Data Vital Health Stat 2001;322:1-36.
26. Qaseem A, Snow V, Shekelle P, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2007;147:633-8.
27. Bruse S, Sood A, Petersen H, et al. New Mexican Hispanic smokers have lower odds of chronic obstructive pulmonary disease and less decline in lung function than non-Hispanic whites. Am J Respir Crit Care Med 2011;184:1254-60.
28. Friedman GD, Klatsky AL, Siegelaub AB. Lung function and risk of myocardial infarction and sudden cardiac death. NEJM 1976;294:1071-5.
29. Lee HM, Le H, Lee BT, et al. Forced vital capacity paired with Framingham risk score for prediction of all-cause mortality. Eur Respir J 2010;36:1002-6.
30. Nakajima K, Kubouchi Y, Muneyuki T, et al. A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome. Chest 2008;134:712-18.
31. Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med 2012;185:435-52.
32. Han MK, Curran-Everett D, Dransfield MT, et al. Racial differences in quality of life in patients with COPD. Chest 2011;140:1169-76.
33. Greenland P, Alpert JS, Beller GA, et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. J Am Coll Cardiol 2010;56:e50-103.
34. Behrendt CE. Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles. Chest 2005;128:1239-44.
35. Braun L, Wolfgang M, Dickersin K. Defining race/ethnicity and explaining difference in research studies on lung function. Eur Respir J 2013;41:1362-70. doi:10.1183/09031936.0009161